Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity

Vaccine

Volumn 15, Issue 4, 1997, Pages 395-401

  Baldridge, Jory R ^a   Vard, Jon R ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

adjuvant; cell mediated immunity; delayed type hypersensitivity (DTH)

Indexed keywords

CD4 ANTIGEN; CORD FACTOR; IMMUNOLOGICAL ADJUVANT; PHOSPHORYL LIPID A; VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; IMMUNOSTIMULATION; LISTERIA MONOCYTOGENES; MOUSE; MYCOBACTERIUM PHLEI; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED ICR; VACCINES, INACTIVATED;

EID: 0031005777     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00199-5     Document Type: Article

References (28)

1. Sell, S. and Hsu, P. Delayed hypersensitivity, immune deviation, antigen processing and T-cell subset selection in syphilis pathogenesis and vaccine design. Immunol. Today 1993, 14, 576-582
2. Scott, P., Natovitz, P., Coffman, R.L., Pearce, E. and Sher, A. Immunoregulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 1988, 168, 1675-1684
3. Singh, I.G., Mukherjee, R., Talwar, G.P. and Kaufmann, S.H. In vitro characterization of T Cells from mycobacterium w-vaccinated mice. Infect. Immun. 1992, 60, 257-263
4. Gustafson, G.L. and Rhodes M.J. Bacterial cell wall products as adjuvants: early Interferon gamma as a marker for adjuvants that enhance protective immunity. Res. Immunol. 1992, 483-488
5. Reiner, S.L. and Seder, R.A. T helper cell differentiation in immune response. Curr. Opin. Immun. 1995, 7, 360-366
6. Skeen, M.J., Ziegler, H.K. Activation of γδ T cells for production of IFN-γ is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-2. J. Immunol. 1995, 154, 5832-5841
7. Ulrich, J.T., Cantrell, J.L, Gustafson, G.L. et al. The adjuvant activity of monophosphoryl lipid A. In: Topics in Vaccine Adjuvant Research (Eds Spriggs, D.R. and Koff, W.C.). CRC Press, Boca Raton, FL, 1991, pp. 133-143
8. Ulrich, J.T. and Myers, K.R. Monophosphoryl lipid A as an adjuvant: past experiences and new directions. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 495-524
9. Takayama, K., Olsen, M., Datta, P. and Hunter, R.L. Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors. Vaccine 1991,9,257-265
10. Myers, K.R. Beining, P., Betts, M., Snippe, H., Inman, J. and Golding, B. Monophosphoryl lipid A behaves as a T-cell-independent type 1 carrier of hapten-specific antibldy responses in mice. Infect. Immun. 1995, 63, 168-174
11. Carozzi, S., Salit, M. and Cantaluppi, A. et al. Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis. J. Clin. Microbiol. 1989, 27, 1748-1753
12. Gustafson, G.L. and Rhodes, M.J. A rationale for the prophylactic use of monophosphoryl lipid A in sepsis and septic shock. Biochem. Biophys. Res. Commun. 1992, 182, 269-275
13. Mitchell, M.S., Harel, W. and Kempf, R.A. et al. Active-specific immunotherapy for melanoma. J. Clin. Oncol. 1990, 8, 856-869
14. MacLean, G.D., Bowen-Yacyshyn, M.B. and Samuel, J. et al. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen. J. Immunother. 1992, 11, 292-305
15. O'Boyle, K.P., Zamore, R. and Adluri, S. et al. Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn. Cancer Res. 1992, 52, 5663-5667
16. Rudbach, J.A., Johnson, D.A. and Ulrich, J.T. Ribi adjuvants: chemistry, biology and utility in vaccines for human and veter-inary medicine. In: The Theory and Practical Application of Adjuvants (Ed. Stewart-Tull, D.E.S.). John Wiley and Sons, Chichester, 1995, pp. 287-313
17. Lemaire, G., Tenu, J., Petit, J. and Lederer, E. Natural and synthetic trehalose diesters as immunomodulators. Med. Res. Rev. 1986, 6, 243-274
18. North, R.J. Cellular mediators of anti-Listeria immunity as an enlarged population of short-lived, replicating T cells. J. Exp. Med. 1973, 138, 342-355
19. Masiki, K.N., Lange, W., Johnson, A.G. and Ribi, E. Enhancement of chemiluminescence and phagocytic activities by nontoxic and toxic forms of lipid A. J. Biol. Response Mod. 1986, 5, 462-469
20. Gustafson, G.L. and Rhodes, M.J. Effects of tumor necrosis factor and dexamethasone on the regulation of interferon-γ induction by monophosphoryl lipid A. J. Immunother. 1994. 15, 129-133
21. Masihi, K.N., Werner, B., Werner, L., Werner, H. and Ribi, E. Trehalose dimycolate from various mycobacterial species induces differing anti-infectious activities in combination with muramyl dipeptide. Infect. Immun. 1985, 50, 938-940
22. Madonna, G.S., Ledney, G.D. and Elliott, T.B. et al. Trehalose dimycolate enhances resistance to infection in neutrophenic animals. Infect. Immun. 1989, 57, 2495-2501
23. Kaufmann, S.H.E., Väth, U. and Thole, J.E.R. et al. Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein. Eur. J. Immunol. 1987, 17, 351-357
24. + cells in acquired immunity. Infect. Immun. 1988, 56, 1920-1925
25. Baldridge, J.R., Barry, R.A. and Hinrichs, D.J. Expression of systemic protection and delayed-type hypersensitivity to Listeria monocytogenes is mediated by different T-cell subsets. Infect. Immun. 1990, 58, 654-658
26. Bishop, D.K. and Hinrichs, D.J. Adoptive transfer of immunity to Listeria monocytogenes: the influence of in vitro stimulation on lymphocyte subset requirements. J. Immunol. 1987,139, 2005-2009
27. Crowle, A.J. Delayed hypersensitivity in the mouse. Adv. Immunol. 1975, 20, 197-264
28. Williams, M.E., Caspar, P. and Oswald, I. et al. Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-β, which down-regulates macrophage antiparasitic activity. J. Immunol. 1995, 154, 4693-4700